-transparent.png){kind=logo}
Interleukin-3 (IL-3), a protein of 140 amino acids, was chemically synthesized by means of an automated peptide synthesizer and was shown to have the biological activities attributed to native IL-3. Assays of synthetic analogues established that an amino terminal fragment has detectable IL-3 activity, but that the stable tertiary structure of the complete molecule was required for full activity. The results demonstrate that automated peptide synthesis can be applied to the study of the structure and function of proteins.
Related Publications
I Clark-Lewis, and
R Aebersold, and
H Ziltener, and
J W Schrader, and
L E Hood, and
S B Kent
May 1994,
Biochemistry,
I Clark-Lewis, and
R Aebersold, and
H Ziltener, and
J W Schrader, and
L E Hood, and
S B Kent
January 1989,
Growth factors (Chur, Switzerland),
I Clark-Lewis, and
R Aebersold, and
H Ziltener, and
J W Schrader, and
L E Hood, and
S B Kent
August 1991,
International journal of hematology,
I Clark-Lewis, and
R Aebersold, and
H Ziltener, and
J W Schrader, and
L E Hood, and
S B Kent
December 1990,
Experimental hematology,
I Clark-Lewis, and
R Aebersold, and
H Ziltener, and
J W Schrader, and
L E Hood, and
S B Kent
September 1990,
The EMBO journal,
I Clark-Lewis, and
R Aebersold, and
H Ziltener, and
J W Schrader, and
L E Hood, and
S B Kent
July 1987,
Experimental cell research,
I Clark-Lewis, and
R Aebersold, and
H Ziltener, and
J W Schrader, and
L E Hood, and
S B Kent
July 1992,
Journal of immunology (Baltimore, Md. : 1950),
I Clark-Lewis, and
R Aebersold, and
H Ziltener, and
J W Schrader, and
L E Hood, and
S B Kent
February 1989,
Revue francaise de transfusion et d'hemobiologie : bulletin de la Societe nationale de transfusion sanguine,
I Clark-Lewis, and
R Aebersold, and
H Ziltener, and
J W Schrader, and
L E Hood, and
S B Kent
December 1986,
Journal of immunology (Baltimore, Md. : 1950),
I Clark-Lewis, and
R Aebersold, and
H Ziltener, and
J W Schrader, and
L E Hood, and
S B Kent
September 1993,
Leukemia,
